天坛生物(600161.SH)拟筹划定增募资不超30亿元 用于产业化基地项目及补充流动资金等
格隆汇 7 月 23日丨天坛生物(600161.SH)公布,公司股票在2020年7月21日、7月22日、7月23日连续三个交易日收盘价格涨幅偏离值累计超过20%,根据《上海证券交易所交易规则》的有关规定,属于股票交易异常波动情形;
经公司自查,公司拟筹划非公开发行股票事项,拟向不超过35名特定投资者非公开发行股票,募集资金总额预计不超过30亿元,主要用于与公司主营业务相关的产业化基地项目及补充流动资金等。此次非公开发行结束后,公司控股股东、实际控制人不会发生变化。
此次非公开发行方案仍在完善中,尚未经公司董事会、股东大会审议,此次发行后续也需获得中国证监会的核准。上述事项能否获得相关批准或核准,以及获得相关批准或核准的时间,均存在不确定性。除此之外,公司不存在其它应披露未披露的重大事项。
目前公司生产经营活动一切正常。后续公司将根据相关规定,对非公开发行股票进展情况持续进行披露。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.